Welcome to the registration website for
Chronic Lymphocytic Leukemia in Rural America

Join us for this educational event and earn 1.0 LIVE CME/CPE/CNE credit hour.  

Montana – Wednesday, February 17, 2021 – 12:00 pm – 1:00 pm MT

During the presentation and live Q&A, you will have the opportunity to submit questions via a message window. Following the video presentation, faculty will respond to these questions in a live 10-minute Q&A session.

Program Overview
Some of the highest incidence rates of chronic lymphocytic leukemia (CLL) occur in the rural states of Montana, Maine, North Dakota, South Dakota, and Kentucky, where disparities in cancer care are also known to exist. This program provides an opportunity for clinicians practicing in these rural states to participate in personalized education designed to both improve disparities in care for these patients and link quality improvement measures to the initiative for reporting to the Centers for Medicare & Medicaid Services (CMS) Quality Payment Program for Small, Underserved, and Rural Practices Merit-based Incentive Payment System (MIPS).

Target Audience
This activity is designed for multidisciplinary healthcare providers including physicians, nurses, pharmacists, and other allied healthcare professionals in rural practices in Montana, Maine, North Dakota, South Dakota and Kentucky who provide medical care to patients with CLL.

Learning Objectives
Upon completion of this educational activity, participants should be able to:


Dr. Farrukh Awan Farrukh T. Awan, MD
Associate Professor of Medicine
Director of Lymphoid Malignancies Program
University of Texas Southwestern Medical Center
Dallas, Texas
Alan Morgan, MPA Alan Morgan, MPA
Chief Executive Officer
National Rural Health Association
Washington, DC
Opal H. Greenway, JD Opal H. Greenway, JD
Stroudwater Associates
Nashville, Tennessee


10 minutes Rural Cancer Care Nationally and Locally
  • Overview of national and local challenges in rural cancer care
  • Incidence, prevalence, and possible etiology of high rates of CLL in the targeted rural states
  • Key local challenges in rural cancer care for patients with CLL
25 minutes Treatment of CLL: Current and Emerging Approaches
  • Optimal treatment regimens for patients with CLL, based on current evidence and expert perspectives, including emerging approaches and key clinical trials
  • Considerations for adherence to therapies in the rural setting
  • Hematologic and nonhematologic adverse events of therapies; monitoring and management approaches in the rural setting
  • Interactive discussion among a CLL national expert and participants, with key recommendations from the expert, conclusions, and key points for practice
15 minutes CMS/MIPS Performance and Quality Improvement in Rural Practice
  • Overview of the Rural Cancer Care Resource Guide
  • Overview of the Centers for Medicare & Medicaid Services (CMS) Quality Payment Program for Small, Underserved, and Rural Practices
  • Discussion of the MIPS Performance and Quality Improvement Worksheet, and working with your local CLL expert and CMS to initiate and document performance and quality improvement related to the CLL educational initiative
10 minutes Audience Q&A Session


MediCom Worldwide, Inc. CME Credit
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-20-032-L01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.

International Pharmacy Preceptors and Canadian Pharmacists: If you are in need of e-Profile ID to participate in an ACPE approved activity, please contact NABP customer service for further assistance as special handling is necessary. NABP customer service can be reached at (847) 391-4406.
MediCom Worldwide, Inc. Nursing Credit
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 20-032-127

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure
Dr. Farrukh Awan has received honoraria as a consultant from AbbVie Inc., AstraZeneca, Blueprint Medicines, Celgene Corporation - A Bristol-Myers Squibb Company, DAVA Oncology, Genentech, Inc., Gilead, Janssen Pharmaceuticals, Inc., Karyopharm Therapeutics, Kite Pharma, MEI Pharma Inc., Pharmacyclics, Inc., and Sunesis Pharmaceuticals, Inc.

Alan Morgan has disclosed no relevant financial relationships.

Opal Greenway has disclosed no relevant financial relationships.

Planning Committee Disclosures
The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, Isabelle Vacher, Vice President of Educational Strategy, Wilma Guerra, Program Director, Andrea Mathis, Project Manager, and Haifa Kassis, Consultant Medical Writer, have no relevant financial relationships.

Americans with Disabilities Act/Special Needs
MediCom Worldwide, Inc. is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veterans status, or sexual orientation.

Instructions for Participation and Credit
There are no fees for participating in this activity.

In order to receive credit, all participants must complete the self-assessment post-test and activity evaluation following the activity. Partial credit will not be awarded for this activity. Participants must receive a minimum score of 70% on the self-assessment to qualify for CE credit.

Certificates for CME and CNE credit may be printed immediately after successfully completing the post-test and activity evaluation.

CPE Credit will be awarded upon completion of a self-assessment and evaluation. Participation verification must be completed within 4 weeks of the activity. Your online CPE certificate will be reported directly to CPE Monitor within 4 weeks of receiving post-activity documentation.

If you have any questions regarding this activity, please contact MediCom Worldwide, Inc. at 800-408-4242, x110 or cjacobus@medicaled.com.

Provided by
MediCom Worldwide, Inc.

Supported by educational grants from AbbVie, Genentech, and Pharmacyclics.